Home -> Law Blog Directory -> Personal Injury Law Blogs -> Bodily Injury Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Bodily Injury BlogAvandia To Be Restricted, FDA Panel Votes
By Edward Bills
An FDA panel has made a recommendation to the agency that the controversial diabetes drug Avandia should either be taken off the market or its sale should be severely restricted. Avandia has recently come under attack for trial results that revealed that patients taking Avandia are at an increased risk of heart attack. In order to keep the drug on the market, the panel decided that the maker, GlaxoSmithKline must complete another clinical trial to prove it is safe.
Full post as published by Bodily Injury Blog on July 15, 2010 (boomark / email).
Darvocet
FDA Expert Panel Votes for Ban
Avandia
alleging heart attacks, increased fracture risk that may have been caused by Avandia.
Insignia
26-Inch Flat-Panel LCD TVs Recalled
Gulf War Syndrome
Panel Confirms it's Real, and Identifies Causes
Pull Vicodin, Percocet
Expert Panel Advises FDA
Ballot Device
Election Systems and Software agrees to pays city of San Francisco $3.5 million settlement after problems with AutoMARK lead to prolonged hand counting of votes.

FDA Panel Votes to Keep Avandia on Market With More Restrictions
Avandia Heart Attack: Questions Still Remain
Avandia Heart Attack Risk, Questions Remain
Physician Takes Issue With Fears Over Avandia Risk
Don't Cry for Avandia Maker Glaxo Just Yet
Avandia Decline Not Affecting GlaxoSmithKline








